Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this live activity for a maximum of 33.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Oral & poster sessions at ENDO are not eligible for CME credit.

Statement of Independence

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, The Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of The Endocrine Society's Annual Meeting Steering Committee (AMSC).  Educational grants support the production costs of the overall activity and are not used to compensate speakers in supported sessions.

Disclaimer

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of The Endocrine Society.

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Discuss state-of-the-art research in endocrinology
• Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, dyslipidemia, and adrenal, metabolic, bone, pediatric, pituitary, thyroid, and reproductive endocrine disorders
• Practice updated clinical skills for more effective diagnosis, management, and treatment of endocrine disorders and related sequelae
• Apply updated knowledge and clinical skills in improving patient care

Target Audience

This continuing medical education activity should be of substantial interest to endocrinologists, pediatric endocrinologists, internists, clinical researchers, and other endocrine professionals.

Disclosure Policy

The faculty, committee members, and staff involved in planning this CME activity are required to disclose to learners any relevant financial relationship(s) that have occurred within the last 12 months with any commercial interest(s) whose products or services are discussed in the CME content. Such relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent faculty with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments. It remains for learners to determine whether financial interests or relationships may influence the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

Faculty, committee member, and presenter disclosures will be published in the ENDO 2011 program materials.

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Conflict of Interest Statement

The scientific content of this activity was developed by The Endocrine Society's Annual Meeting Steering Committee, independent of grant support and in accordance with the ACCME's Essential Areas and Elements, including the Standards for Commercial Support. The commercial supporters of this meeting have no influence over topics or speakers.

Policy on Unlabeled/Off-Label Use

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

Privacy & Confidentiality Statement

The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

Acknowledgement of Commercial Support

Educational grants support the production costs of the overall activity and are not used to compensate speakers in supported sessions.

As of May 10, 2011, the following companies have provided educational grant support for ENDO 2011:

• Abbott Laboratories
• Allergan, Inc.
• Amgen
• Amylin Pharmaceuticals, Inc, and Lilly USA, LLC
• Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
• Corcept Therapeutics, Inc.
• Daiichi Sankyo, Inc.
• Endo Pharmaceuticals Inc.
• Enobia Pharma, Inc.
• Genentech, Inc.
• Genzyme
• Ipsen, US
• Kowa Pharmaceuticals America, Inc. and Lilly USA, LLC
• Lilly USA, LLC
• Medtronic Diabetes
• Merck & Co., Inc.
• Novartis Pharmaceutical Corporation
• Novo Nordisk Inc.
• Pfizer, Inc.
• sanofi-aventis U.S.
• Theratechnologies Inc.